New AMA policy targets unapproved peptide compounding

The American Medical Association has adopted a policy urging HHS, the FDA and other federal regulators to “immediately rescind” administrative policies or directives that ease restrictions on compounding and distributing synthetic peptides that haven’t been approved by the FDA.  The AMA cited concerns that unapproved peptides lack the safety, efficacy and quality evidence needed to […] The post New AMA policy targets unapproved peptide compounding appeared first on Becker's Hospi...